Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Journal of Crohn'S & Colitis|April 29, 2017
Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel DiseaseKi Jung Lim, So Jung Lee, Sunghwan Kim, et al.
Cancer Letters|September 16, 2018
KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancerYeo Wool Kang, Ji Eun Lee, Kyung Hee Jung, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.
ACS Nano|June 12, 2023
Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor ImmunityGyu Hwan Hyun, Da-Hye Jeong, Yoon Young Yang, et al.
Scientific Reports|May 21, 2022
Comparative analysis of mesenchymal stem cells cultivated in serum free mediaJoo Youn Lee, Min Hee Kang, Ji Eun Jang, et al.
Journal of the National Cancer Institute|October 6, 2021
A Serum Marker for Early Pancreatic Cancer With a Possible Link to DiabetesHoonsik Nam, Soon-Sun Hong, Kyung Hee Jung, et al.
American Journal of Cancer Research|October 13, 2022
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancerSoyeon Ko, Kyung Hee Jung, Young-Chan Yoon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
Pageof 22